Siqing Jiang, Xingxiang Pu, Lin Wu, Yongzhong Luo, Qiming Wang, Jin Zhou, Guanming Jiang, Qing Bu, Min Li, Juan Li, Juntao Zou, Yu Zhang, Qian Chu, Pian Liu, Fang Ma, Ruiguang Zhang, Li Zhuang, Yuqing Mo, Jia Li, Ni Xie. "A real-world analysis of dyslipidemia and attributable risk in lorlatinib-treated ALK-positive lung cancer patients.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e24190